Hypertension Produced by Reductions in Uterine Perfusion in the Pregnant Rat
- 1 October 2005
- journal article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 46 (4) , 1022-1025
- https://doi.org/10.1161/01.hyp.0000175476.26719.36
Abstract
Inflammatory cytokines such as tumor necrosis factor (TNF)-alpha are elevated in preeclamptic women and are thought to be an important link between placental ischemia and endothelial dysfunction. The purpose of this study was to determine the role of TNF in mediating hypertension in response to chronic reductions in uterine perfusion (RUPPs) in pregnant rats. Arterial pressure was significantly higher in RUPP rats (138+/-1 mm Hg) than in pregnant rats (107+/-1 mm Hg). Serum TNF-alpha levels in the RUPP rats were 17+/-4 pg/mL compared with 8+/-1 pg/mL in normal pregnant rats. To determine the long-term effects of a 2- to 3-fold elevation in plasma TNF-alpha on renal and systemic hemodynamics in pregnant rats, we infused TNF-alpha for 5 days at a rate of 50 ng/d during days 14 to 19 of gestation in pregnant rats. Serum levels were 7+/-2 pg/mL in the control pregnant rats and 14+/-2 pg/mL in the TNF-alpha-treated pregnant rats. Mean arterial pressure was higher in the TNF-alpha-treated pregnant rats (123+/-3 mm Hg) compared with pregnant controls (96+/-3 mm Hg) at day 19 of gestation. TNF-alpha increased renal vascular resistance in pregnant rats by 182%. Renal plasma flow was 5.4+/-1.2 mL/min in the TNF-alpha-treated group and 9.2+/-1.6 mL/min in the control group. Glomerular filtration rate was 1.7+/-0.4 mL/min in the TNF-alpha-treated group and 2.6+/-0.4 mL/min in the control group. In summary, these data suggest that TNF-alpha may play an important role in mediating the increased arterial pressure in response to chronic RUPPs in pregnant rats.Keywords
This publication has 15 references indexed in Scilit:
- Placental Cytokines and the Pathogenesis of PreeclampsiaAmerican Journal of Reproductive Immunology, 1997
- Tumor Necrosis Factor: Function, Release and ClearanceCritical Reviews in Immunology, 1996
- Interleukin‐6, turnour necrosis factor and soluble turnour necrosis factor receptors in women with pre‐eclampsiaBJOG: An International Journal of Obstetrics and Gynaecology, 1995
- Bioactive tumour necrosis factor α in pre‐eclamptic patients with and without the HELLP syndromeBJOG: An International Journal of Obstetrics and Gynaecology, 1994
- Endothelial cell activation by tumour necrosis factor-alpha (TNF-α and the development of pre-eclampsiaClinical and Experimental Immunology, 1994
- A new animal model for human preeclampsia: Ultra-lowdose endotoxin infusion in pregnant ratsAmerican Journal of Obstetrics and Gynecology, 1994
- Tumor necrosis factor-α is elevated in plasma and amniotic fluid of patients with severe preeclampsiaAmerican Journal of Obstetrics and Gynecology, 1994
- Pediatric do-not-resuscitate ordersCritical Care Medicine, 1993
- Tumor necrosis factor-mediated release of platelet-derived growth factor from cultured endothelial cells.The Journal of Experimental Medicine, 1987
- Plasma fibronectin levels in preeclampsia: A possible biochemical marker for vascular endothelial damageAmerican Journal of Obstetrics and Gynecology, 1984